Abdulrahman Hommadi

Identify and Assess Drug Interactions with Atorvastatin in Inpatient Care

Ibrahim Dighriri, Abdulrahman Hommadi, Hatim Zaeri, Rahaf Aldajany, Rahaf Alotaibi, Fai Aljuaid, Shoug Aljuaid, Abdullah Madkhali, Saleh Ghulaysi, Abeer Alanazi, Sarah Alburaidi, Amal Hamdan, Hassan Alzahrani, Razan Musharraf & Bashaier Albutaih · Journal of Pharmaceutical Research International · 2021

Background: Atorvastatin is a recent HMG-COA reductase inhibitor used to treat primary hypercholesterolemia, homozygous familial hypercholesterolemia, and mixed dyslipidemias. It is also taken to prevent heart disease, including strokes and heart attacks. In addition, Atorvastati...

Open access Research Article 10.9734/jpri/2021/v33i54A33750

Role of Therapeutic Drug Monitoring in Medication Safety, Physicians Perception, and Practice

Khaled Alhusayni, Ibrahim Dighriri, Abdullah Althomali, Abdulaziz Alkhammash, Faisal Alharthi, Adel Alharthi, Theaar Alotaibi, Saeed Alzahrani, Abdulrahman Hommadi, Fahad Rajab, Majed Alfaifi, Ibrahim Mobarki, Sultan Alrubaiei, Rasha Alqahtani & Shaden Bin Howimel · Journal of Pharmaceutical Research International · 2021

Introduction: Patients admitted to the hospital will receive various drugs, each carrying the risk of error. Medication errors concern our healthcare system, especially considering the relatively high number of patients admitted to hospitals. Assuming that each patient receives a...

Open access Research Article 10.9734/jpri/2021/v33i51A33466